Key statistics
As of last trade 2Seventy Bio Inc (TSVT:NSQ) traded at 4.81, -24.78% below its 52-week high of 6.40, set on Feb 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.89 |
---|---|
High | 4.89 |
Low | 4.77 |
Bid | 4.80 |
Offer | 4.83 |
Previous close | 4.72 |
Average volume | 235.76k |
---|---|
Shares outstanding | 51.50m |
Free float | 49.40m |
P/E (TTM) | -- |
Market cap | 243.07m USD |
EPS (TTM) | -3.06 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 15:59 BST.
More ▼
- 2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare Conference
- 2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
- 2seventy bio to Report Second Quarter 2024 Financial Results on August 7, 2024
- 2seventy bio Announces Sale of Hemophilia A Candidate and MegaTAL In Vivo Gene Editing Technology to Novo Nordisk for up to $40 million